Ysios will create its second fund to invest in biotechnology companies before 2015
Ysios levantará su segundo fondo para invertir en empresas biotecnológicas antes de 2015
Intel ID : 219310
Synopsis |
Venture capital firm Ysios will create a second fund to invest in biotechnology companies, with EUR 100m. To create this fund, the firm has partners that have invested in the first fund: high net worth individuals, family offices, a financial institution and public regional entities.
(content in spanish)
La firma de venture capital Ysios Capital Partners levantará su segundo fondo para invertir en empresas biotecnológicas. La dotación del mismo ascenderá a EUR 100m. Para la constitución de este segundo fondo la entidad ya cuenta con socios que han participado en el primer fondo: grandes patrimonios, family offices, alguna entidad financiera y entidades públicas regionales. |
Intel ID | 219310 | ||
Value | EUR 100,00m | ||
Native Currency | Euro (EUR) | ||
Financial Data - Ysios Capital Partners
(31 Dec 2023) |
Revenue: - EBITDA: - |
||
Date |
![]() |
||
Country | ![]() |
||
Region | |||
Continent | ![]() |
||
Geography | ![]() |
||
Subsector (Old TTR Sectors) |
|
||
Type |
![]() |
||
Intel Grade |
![]() |
||
Source |
![]() |
||
Tags | ![]() |
Bidder
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
25.01.10 Venture Capital 25 Financial Services / 25.01 Banking & Investment |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.